TELADOC HEALTH INC.DL-001 WKN: A14VPK ISIN: US87918A1051 Kürzel: TDOC Forum: Aktien Thema: Hauptdiskussion

$TDOC D/G $203 Truist Securities $153 Deutsche Bank $180 KeyBanc $185 Cantor Fitzgerald $260 BTIG $225 Citi $175 BofA Securities $218 SVB Leerink $170 Barclays $220 Oppenheimer

And Im not your translator. Dont be lazy.

Grassi bobby is right. As a native you actually should recognize a cit.

Value hat nur Aussagen des Managements zitiert. Lass es doch von Google übersetzen.

Teladoc bekommen wir in kurzer Zeit unter 100 Euro.

ValueFirst7.....I am very astonished that you speaks english so fluently. Please try to translate because not everybody is understanding all You are posting.... don't forget Next Time in German Language....

Bin jetzt auch durch den Dip eben mit dabei, nachdem ich im Mai bei 116€ nicht mehr reingekommen bin und ich auf den angefahrenen Zug nicht mehr aufgesprungen bin.

And what I would say is hold tight a little bit for us. We anticipate having an Investor and Analyst Day toward the -- in the fourth quarter, where we expect to give much more insight into the long-term growth algorithm, the levers for growth and why we feel so confident about continuing to deliver on both the top-line and bottom-line growth over the next several years.

And we are really excited by the launch of myStrength Complete. It is, as Jason talked about a few minutes ago, a really important proof point for the coming together of the assets and capabilities across Teladoc and the legacy Livongo.

Yeah. So Charles, nice job sneaking in two questions there. With respect to HCSC, we will see a significant set of growth in the first quarter, in the beginning of '22. But I would expect that will grow and continue to grow over at least to probably three years' time.

Yeah. But just to punch one point home, the pipeline for Primary360 that we are seeing is very, very strong. If I look at the growth in the pipeline sequentially, we are seeing real strength in the pipeline. And that, to me, is one of the important markers for our confidence in growth as we look ahead.

In the international market during the second quarter, we signed an agreement to expand our relationship with Telefonica. The new partnership makes our telemedicine services available to more than 60 million customers of Vivo, Telefonica's Brazilian subsidiary and the leading telecom company in that country.

During the second quarter, we signed several new deals to launch Primary360. I'm pleased to report that just this week, we signed a significant Primary360 contract with a national payer, and we're in late-stage discussions with several other health plans. As we turn to hospitals and health systems, it's evident that we are uniquely positioned to help them improve outcomes and reduce costs. During the second quarter, we signed multiple new chronic care agreements in the health system market, including a significant contract with a large Florida-based health system to bring our whole-person diabetes and cardiovascular programs to their at-risk populations.

I'm very proud to report that during the second quarter, we signed an expansive new agreement with HCSC, the fifth largest health insurer in the U.S. As part of this agreement, we will provide our suite of chronic care solutions across their commercial fully insured members in several markets and significantly expand our products offered to their ASO clients. Beginning in 2022, we will provide eligible HCSC members in fully insured plans with access to our diabetes and hypertension programs.

schade- hatte auch mehr erhofft. Der Markt ist noch nicht da- dauert noch , bleibe long mit 10k da ich hier die Verluste (25%) nicht realisieren will- totes Geld bis dahin...

Danke für die letzten, vernünftigen Kommentare. Nach den Kommentaren heute Nacht hatte ich schon geplant, zu verkaufen.